Home › Smoldering Multiple Myeloma › Massachusetts › Boston
Smoldering Multiple Myeloma clinical trials in Boston, MA
6 studies for Smoldering Multiple Myeloma are looking for participants at sites in and around Boston (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Compare Linvoseltamab and Daratumumab Treatment in High-Risk Smoldering Multiple Myeloma (HR-SMM)
RecruitingPhase 3
- Dana Farber / Harvard Cancer Center, Boston
Screening for AL Amyloidosis in Smoldering Multiple Myeloma
RecruitingObservational study
- Tufts Medical Center, Boston
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
RecruitingPhase 3
- Tufts Medical Center, Boston
Immuno-PRISM (PRecision Intervention Smoldering Myeloma)
RecruitingPhase 2
- Dana Farber Cancer Institute, Boston
A Proof-of-Concept Study to Learn Whether Linvoseltamab Can Eliminate Abnormal Plasma Cells That May Lead to Multiple Myeloma in Adult Patients With High-Risk Monoclonal Gammopathy of Undetermined Significance or Non-High-Risk Smoldering Multiple Myeloma
RecruitingPhase 2
- Dana-Farber Cancer Institute, Boston
Study of MGUS, Smoldering Myeloma, Early MDS and CLL to Assess Molecular Events of Progression and Clinical Outcome
RecruitingObservational study
- Dana-Farber Cancer Institute, Boston
Smoldering Multiple Myeloma trials in other cities
- New York City, NY6 studies
- Atlanta, GA5 studies
- Durham, NC3 studies
- Denver, CO3 studies
- Houston, TX3 studies
- Columbus, OH3 studies
- Edison, NJ3 studies
- Salt Lake City, UT3 studies
Other studies in Boston
- Breast Cancer110 studies
- Cancer (all types)90 studies
- Non-Small Cell Lung Cancer87 studies
- Lung Cancer63 studies
- Colorectal Cancer62 studies
- Ovarian Cancer62 studies
- Metastatic Cancer61 studies
- Prostate Cancer56 studies
- Endometrial Cancer51 studies
- Depression50 studies
- Heart Failure46 studies
- Multiple Myeloma45 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.